Drug Information

Drug General Information
Drug ID
D01RBR
Former ID
DIB001234
Drug Name
SGS742
Indication Schizophrenia [ICD9: 295; ICD10:F20] Phase 2 [527226]
Company
Saegis Pharmaceuticals
Target and Pathway
Target(s) Gamma-aminobutyric acid B receptor Target Info Modulator [527226]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
GABAergic synapse
Estrogen signaling pathway
Morphine addiction
Reactome Activation of G protein gated Potassium channels
G alpha (i) signalling events
Class C/3 (Metabotropic glutamate/pheromone receptors)
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
WikiPathways GPCRs, Class C Metabotropic glutamate, pheromone
Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
Potassium Channels
GPCR ligand binding
GPCR downstream signaling
References
Ref 527226SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochem Pharmacol. 2004 Oct 15;68(8):1479-87.
Ref 527226SGS742: the first GABA(B) receptor antagonist in clinical trials. Biochem Pharmacol. 2004 Oct 15;68(8):1479-87.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.